Oxford Nanopore Technologies' Target Price Drops

JPMorgan Chase & Co. recently lowered the target price of Oxford Nanopore Technologies, prompting other analysts to weigh in on the stock. Berenberg Bank and Barclays also lowered their target prices, while Peel Hunt began covering the company with a “reduce” rating. Oxford Nanopore Technologies develops and commercializes nanopore-based sensing technology, offering a range of products for DNA and RNA sequencing. The company’s stock has a 50-day moving average price of $2.77 and a 200-day moving average price of $2.99, with a twelve-month low of $2.20 and a twelve-month high of $5.30. It’s important to consider the opinions of multiple analysts before making investment decisions.

Oxford Nanopore Technologies logo

JPMorgan Chase & Co. recently lowered the target price of Oxford Nanopore Technologies (OTC:ONTTF – Get Rating) from GBX 460 ($5.65) to GBX 390 ($4.79) in a research report. However, other investment analysts have also given their opinions on the stock. For instance, Berenberg Bank reduced its target price for Oxford Nanopore Technologies from GBX 671 ($8.24) to GBX 529 ($6.50) in a report released on February 13th. Similarly, Barclays dropped their target price from GBX 420 ($5.16) to GBX 400 ($4.91) in a report published on February 7th. Meanwhile, Peel Hunt recently began covering the company, giving it a “reduce” rating on the stock.

The Fly logo

As of Thursday, the Oxford Nanopore Technologies stock opened at $2.45. The company’s 50-day and 200-day moving average prices stand at $2.77 and $2.99, respectively. The stock has a twelve-month low of $2.20 and a twelve-month high of $5.30.

Oxford Nanopore Technologies develops and commercializes a technology platform that uses nanopore-based sensing to analyze various types of molecules. It offers several products such as MinION, GridION, MinION Mk1C, Flongle, GridION Mk1, PromethION 2 Solo and PromethION 2, PromethION 24 and PromethION 48, and VolTRAX. These products include portable devices for DNA and RNA sequencing, self-contained benchtop devices for analyzing up to five MinION or Flongle flow cells, and benchtop nanopore sequencers for multiple users.

Investment analysts’ opinions can significantly influence a stock’s price, and it’s not uncommon for different analysts to have different opinions. Therefore, it is essential to consider the opinions of multiple analysts before making investment decisions.

Don’t miss interesting posts on Famousbio

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reduce IT Employee Fatigue: Gartner’s Four-Step Plan

Successful organizations must involve top executives, lower organizational layers, IT, and business…

Major Changes to Professional Award

The Professional Employees Award 2020 is set to undergo changes proposed by…

Uber stock gets RBC’s “outperform” rating

Uber Technologies’ stock has recently been given an “outperform” rating by Royal…

Mastering Digital Marketing Science

Denner Liebert shared his expertise in digital marketing during his speech at…